2026 NPPES data Internal Medicine Physician NPI 1114928793 MD
Verify on CMS →

MARK CASTELLAW, MD

Internal Medicine Physician in GERMANTOWN, Tennessee. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
13K
Medicare Part D claims · 847 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.5182/100
▼ 7 pts below national avg 83.1 · [object Object]
Industry payments
$551.36
28 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK CASTELLAW, MD reported a CMS MIPS final score of 76.5182/100 — below the 83.1 national average — and filed 12,791 Medicare Part D claims in 2023.

76.5182/100
MIPS score · -7 vs avg
13K
Part D claims, 2023
89%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK CASTELLAW, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

77 21st percentile higher than 21% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK CASTELLAW, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK CASTELLAW, MD?

Below national average

NPI registry status

Active

Issued 08/09/2005

NPI 1114928793

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

12,791 371% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

76.5182/100 6.581800000000001% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Tennessee

How Internal Medicine Physician compares to other specialties among Tennessee providers

Tennessee providers

Internal Medicine Physician share within Tennessee

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Tennessee

Medicare quality performance — MIPS

MARK CASTELLAW, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average

Below national average
MIPS Final Score
76.5182/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 76.5182/100 vs national avg 83.1

0%100%National avg83%76.5%
MIPS final score (Internal Medicine Physician) — 76.5182/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK CASTELLAW, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 8040 WOLF RIVER BOULEVARD, GERMANTOWN, TN, 38138, with a listed phone of (901) 726-0200. NPI 1114928793 was issued on 08/09/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CASTELLAW most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 12,791 prescription claims written by this provider, covering 847 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 11% brand-name and 89% generic by claim count, with an opioid prescribing rate of 1.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.5182/100 for the 2023 performance year (Quality 70.5342, Cost 66.1931), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8040 WOLF RIVER BOULEVARD
GERMANTOWN, TN 38138

Provider Details

NPI 1114928793
Specialty Internal Medicine Physician
Credentials MD
Gender Male
NPI Issued 08/09/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.5182
Final Score
Avg: 83.1
70.5342
Quality
66.1931
Cost
82
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK CASTELLAW, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BAPTIST MEMORIAL MEDICAL GROUP, INC.
ATOKA, TN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK CASTELLAW, MD. Source: openpaymentsdata.cms.gov.

Total received

$551

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MARK CASTELLAW, MD — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 12,791 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

12,791
Total Claims
$1.0M
Total Drug Cost
847
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
27,955
Total Day Supply
814,197
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$851K
Generic Drug Cost
$184K
Opioid Claims
218 (1.7% rate)
Antibiotic Claims
319

Patient Demographics

Average Patient Age
76.1 years
Avg HCC Risk Score
1.15
Gender Split
52% female / 48% male
Age Distribution
<65: 23, 65-74: 365, 75-84: 324, 85+: 135

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK CASTELLAW, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
632
Atorvastatin Calcium
601
Losartan Potassium
549
Levothyroxine Sodium
510
Pantoprazole Sodium
490
Rosuvastatin Calcium
398
Omeprazole
372
Metoprolol Succinate
337
Ezetimibe
309
Gabapentin
305

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How MARK CASTELLAW, MD fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

MARK CASTELLAW, MD's 12,791 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Tennessee

Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as CASTELLAW.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK CASTELLAW, MD's specialty?
MARK CASTELLAW, MD specializes in Internal Medicine Physician and practices in GERMANTOWN, Tennessee. Credentials: MD.
How much does MARK CASTELLAW, MD prescribe under Medicare Part D?
In 2023, MARK CASTELLAW, MD wrote 12,791 Medicare Part D claims totaling $1.0M in drug costs for 847 beneficiaries.
What is MARK CASTELLAW, MD's Medicare quality score?
MARK CASTELLAW, MD has a CMS MIPS Final Score of 76.5182/100 (Quality: 70.5342, Cost: 66.1931). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK CASTELLAW, MD located?
MARK CASTELLAW, MD is located at 8040 WOLF RIVER BOULEVARD, GERMANTOWN, TN, 38138. Phone: (901) 726-0200.
What is MARK CASTELLAW, MD's NPI number?
MARK CASTELLAW, MD's National Provider Identifier (NPI) is 1114928793, issued on 08/09/2005.
Does MARK CASTELLAW, MD prescribe more brand-name or generic drugs?
MARK CASTELLAW, MD's prescribing is 11% brand-name and 89% generic drugs by claim count, with $851K in brand drug costs.
Does MARK CASTELLAW, MD prescribe opioids?
Yes, MARK CASTELLAW, MD had 218 opioid claims in 2023 with an opioid prescribing rate of 1.7%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does MARK CASTELLAW, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK CASTELLAW, MD's most frequently prescribed drugs include Amlodipine Besylate, Atorvastatin Calcium, Losartan Potassium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK CASTELLAW, MD accept Medicare?
MARK CASTELLAW, MD appears in CMS Medicare data with 12,791 Part D claims and 847 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK CASTELLAW, MD's credentials?
MARK CASTELLAW, MD's NPI is 1114928793 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology